Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Consolidated revenues by Year
Consolidated revenues — Other countries (legacy breakout, $M) ($M)
Gilead Sciences Consolidated revenues: $2,602M in FY2017, down 44.3% from a year earlier. No newer figure appears in the documents we track.
Where the FY2017 figure comes from
Source: Form 10-K (filed 2018-02-27) ↗
Reported in Form 10-K Segment & Geographic Information.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Consolidated revenues — Other countries (legacy breakout, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2017 | Dec 31, 2017 | 2,602 | -44.3% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 4,671 | +20.5% | Form 10-K (filed 2018-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 3,877 | +219.6% | Form 10-K (filed 2018-02-27) ↗ |
| FY2014 | Dec 31, 2014 | 1,213 | – | Form 10-K (filed 2017-02-27) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Consolidated revenues ($M), annual FY2014–FY2017 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/geo-rev-other-cty
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.